Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H OERTEL

Showing results (141-150 of 678) with videos related to

Pageof 68
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 1995
Tremor as a factor in prolonged reaction times of parkinsonian patientsG Staude, W Wolf, M Ott, et al.
CNS Drugs|September 16, 2008
Cost effectiveness of pharmacotherapies in early Parkinson's diseaseKarla M Eggert, Jens P Reese, Wolfgang H Oertel, et al.
European Neurology|January 30, 2009
Awareness and knowledge of the clinical practice guideline on Parkinson's disease among German neurologistsKarla Eggert, Astrid Larisch, Richard Dodel, et al.
Der Nervenarzt|October 1, 1990
[Local injection treatment with botulinum toxin A in blepharospasm, Meige syndrome and hemifacial spasm. Observations in 106 patients]A O Ceballos-Baumann, T Gasser, R Dengler, et al.
Journal of Neurochemistry|February 1, 1987
Taurine biosynthesis in rat brain: a new specific and sensitive microassay of cysteine sulfinate decarboxylase (CSDI) activity through selective immunotrapping and its use for distribution studiesF Legay, V K Weise, W H Oertel, et al.
Calcified Tissue International|June 24, 2010
Changes in cross-sectional area of spinal canal and vertebral body under 2 years of teriparatide treatment: results from the EUROFORS studyR Schnell, C Graeff, A Krebs, et al.
Archives of Neurology|November 1, 1992
Apomorphine test for dopaminergic responsiveness in patients with previously untreated Parkinson's diseaseT Gasser, J Schwarz, G Arnold, et al.
Experimental Neurology|July 6, 2000
Systemic treatment with GM1 ganglioside improves survival and function of cryopreserved embryonic midbrain grafted to the 6-hydroxydopamine-lesioned rat striatumJ Sautter, G U Höglinger, W H Oertel, et al.
Seizure|August 21, 2002
Late-onset myoclonic epilepsy in Down's syndrome (LOMEDS)J C Möller, H M Hamer, W H Oertel, et al.
Glia|June 1, 1996
Cellular immune reactions in brain transplantation: effects of graft pooling and immunosuppression in the 6-hydroxydopamine rat model of Parkinson's diseaseS C Schwarz, A R Kupsch, R Banati, et al.
Pageof 68

Showing results (141-150 of 678) with videos related to

Sort By:
Pageof 68
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 1995
Tremor as a factor in prolonged reaction times of parkinsonian patientsG Staude, W Wolf, M Ott, et al.
CNS Drugs|September 16, 2008
Cost effectiveness of pharmacotherapies in early Parkinson's diseaseKarla M Eggert, Jens P Reese, Wolfgang H Oertel, et al.
European Neurology|January 30, 2009
Awareness and knowledge of the clinical practice guideline on Parkinson's disease among German neurologistsKarla Eggert, Astrid Larisch, Richard Dodel, et al.
Der Nervenarzt|October 1, 1990
[Local injection treatment with botulinum toxin A in blepharospasm, Meige syndrome and hemifacial spasm. Observations in 106 patients]A O Ceballos-Baumann, T Gasser, R Dengler, et al.
Journal of Neurochemistry|February 1, 1987
Taurine biosynthesis in rat brain: a new specific and sensitive microassay of cysteine sulfinate decarboxylase (CSDI) activity through selective immunotrapping and its use for distribution studiesF Legay, V K Weise, W H Oertel, et al.
Calcified Tissue International|June 24, 2010
Changes in cross-sectional area of spinal canal and vertebral body under 2 years of teriparatide treatment: results from the EUROFORS studyR Schnell, C Graeff, A Krebs, et al.
Archives of Neurology|November 1, 1992
Apomorphine test for dopaminergic responsiveness in patients with previously untreated Parkinson's diseaseT Gasser, J Schwarz, G Arnold, et al.
Experimental Neurology|July 6, 2000
Systemic treatment with GM1 ganglioside improves survival and function of cryopreserved embryonic midbrain grafted to the 6-hydroxydopamine-lesioned rat striatumJ Sautter, G U Höglinger, W H Oertel, et al.
Seizure|August 21, 2002
Late-onset myoclonic epilepsy in Down's syndrome (LOMEDS)J C Möller, H M Hamer, W H Oertel, et al.
Glia|June 1, 1996
Cellular immune reactions in brain transplantation: effects of graft pooling and immunosuppression in the 6-hydroxydopamine rat model of Parkinson's diseaseS C Schwarz, A R Kupsch, R Banati, et al.
Pageof 68